The RELA protein is treated as a potential cancer biomarker, responsible for cytokine production and inflammatory bowel disease [54, 55], when AKT1 is a protein that aids in the correct growth and operation of the nervous system [56–58]. The gene discussed is AKT1; the disease is inflammatory bowel disease.